MedPath

TransplantLines Food and Nutrition Biobank and Cohort Study (TxL-FN)

Registration Number
NL-OMON22374
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

1: Frenay AR, Kayacelebi AA, Beckmann B, Soedamah-Muhtu SS, de Borst MH, van den Berg E, van Goor H, Bakker SJ, Tsikas D. High urinary homoarginine excretion is associated with low rates of all-cause mortality and graft failure in renal transplant recipients. Amino Acids. 2015 Sep;47(9):1827-36. doi: 10.1007/s00726-015-2038-6. Epub 2015 Jul 5. PubMed PMID: 26142633. <br><br> 2: Frenay AR, van den Berg E, de Borst MH, Beckmann B, Tsikas D, Feelisch M, Navis G, Bakker SJ, van Goor H. Plasma ADMA associates with all-cause mortality in renal transplant recipients. Amino Acids. 2015 Sep;47(9):1941-9. doi: 10.1007/s00726-015-2023-0. Epub 2015 Jun 16. PubMed PMID: 26077715; PubMed Central PMCID: PMC4549386. <br><br> 3: Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A. Calcification Propensity and Survival among Renal Transplant Recipients. J Am Soc Nephrol. 2016 Jan;27(1):239-48. doi: 10.1681/ASN.2014070670. Epub 2015 Apr 29. PubMed PMID: 25925688; PubMed Central PMCID: PMC4696561. <br><br> 4: Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJ, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, De Borst MH; NIGRAM consortium. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients. Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1310-6. doi: 10.1016/j.numecd.2014.06.006. Epub 2014 Jun 23. PubMed PMID: 25063539. <br><br> 5: Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1553-62. doi: 10.2215/CJN.08690813. Epub 2014 Jul 3. PubMed PMID: 24993447; PubMed Central PMCID: PMC4152815. <br><br> 6: van den Berg E, Pasch A, Westendorp WH, Navis G, Brink EJ, Gans RO, van Goor H, Bakker SJ. Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients. J Am Soc Nephrol. 2014 Jun;25(6):1303-12. doi: 10.1681/ASN.2013050497. Epub 2014 Feb 7. PubMed PMID: 24511127; PubMed Central PMCID: PMC4033367. <br><br> 7: Snijder PM, van den Berg E, Whiteman M, Bakker SJ, Leuvenink HG, van Goor H. Emerging role of gasotransmitters in renal transplantation. Am J Transplant. 2013 Dec;13(12):3067-75. doi: 10.1111/ajt.12483. Epub 2013 Oct 30. Review. PubMed PMID: 24266966. <br><br> 8: Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, Kema IP, Muskiet FA, Navis G, Bakker SJ, de Borst MH. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. PLoS One. 2012;7(10):e47991. doi: 10.1371/journal.pone.0047991. Epub 2012 Oct 31. PubMed PMID: 23118917; PubMed Central PMCID: PMC3485347. <br><br> 9: van den Berg E, Engberink MF, Brink EJ, van Baak MA, Joosten MM, Gans RO, Navis G, Bakker SJ. Dietary acid load and metabolic acidosis in renal transplant recipients. Clin J Am Soc Nephrol. 2012 Nov;7(11):1811-8. doi: 10.2215/CJN.04590512. Epub 2012 Aug 30. PubMed PMID: 22935845; PubMed Central PMCID: PMC3488949. <br><br> 10: van den Berg E, Engberink MF, Brink EJ, van Baak MA, Gans RO, Navis G, Bakker SJ. Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr. 2013 Apr 28;109(8):1463-70. doi: 10.1017/S0007114512003455. Epub 2012 Aug 21. PubMed PMID: 22906209. <br><br> 11: van den Berg E, Geleijnse JM, Brink EJ, van Baak MA, Homan van der Heide JJ, Gans RO, Navis G, Bakker SJ. Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant. 2012 Aug;27(8):3352-9. doi: 10.1093/ndt/gfs069. Epub 2012 Apr 12. PubMed PMID: 22499024.

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
1000
Inclusion Criteria

More than one year after transplantation, prognosis > 1 year, stable outpatients situation

Exclusion Criteria

Acute illnesses, fever, current hospitalisation

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Graft failure and all-cause mortality
Secondary Outcome Measures
NameTimeMethod
Cause-specific graft failure<br>Cause-specific mortality<br>Change in renal function<br>Development of new-onset diabetes after transplantation
© Copyright 2025. All Rights Reserved by MedPath